| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.1M | -40.6% |
| R&D Expense | $78.4M | +33.5% |
| SG&A Expense | $28.9M | +6.7% |
| Operating Income | -$106.5M | -47.3% |
| Income Tax | $0 | — |
| Net Income | -$86.0M | -19.1% |
| EPS (Basic) | -$10.10 | +0.4% |
| EPS (Diluted) | -$10.10 | +0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.4M | +30.4% |
| Current Assets | $219.6M | -1.3% |
| Total Assets | $260.3M | +12.0% |
| Current Liabilities | $22.5M | -4.6% |
| Total Liabilities | $48.6M | +101.0% |
| Stockholders' Equity | $211.7M | +1.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.0M | -26.0% |
| Capital Expenditures | $3.0M | +135.4% |
| Investing Cash Flow | $59.2M | +164.9% |
| Financing Cash Flow | $74.8M | -44.6% |
| Free Cash Flow | -$101.0M | -27.8% |